Alain Pierré

498 total citations
15 papers, 406 citations indexed

About

Alain Pierré is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Alain Pierré has authored 15 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Alain Pierré's work include Cancer therapeutics and mechanisms (6 papers), Synthesis and biological activity (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Alain Pierré is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Synthesis and biological activity (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Alain Pierré collaborates with scholars based in France and Greece. Alain Pierré's co-authors include Ghanem Atassi, Laurence Kraus‐Berthier, Michel Koch, François Tillequin, Jean-Pierre Bizzari, Stéphane Léonce, Sylvie Michel, Stéphane Depil, Nicolas Guilbaud and Anne Vincent‐Salomon and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Alain Pierré

14 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Pierré France 8 270 135 107 78 63 15 406
An‐Chi Tsai Taiwan 10 267 1.0× 77 0.6× 56 0.5× 60 0.8× 40 0.6× 12 384
Gabriela Kořínková Czechia 8 381 1.4× 183 1.4× 49 0.5× 68 0.9× 27 0.4× 12 501
Nagashayana Natesh India 6 369 1.4× 114 0.8× 66 0.6× 39 0.5× 61 1.0× 6 516
Ram Kumar Singh India 10 401 1.5× 163 1.2× 43 0.4× 78 1.0× 26 0.4× 15 586
Christine Basmadjian France 10 417 1.5× 106 0.8× 86 0.8× 43 0.6× 23 0.4× 11 588
J Duraj Slovakia 14 301 1.1× 125 0.9× 56 0.5× 52 0.7× 56 0.9× 51 494
James D. Liddil United States 12 253 0.9× 86 0.6× 97 0.9× 46 0.6× 30 0.5× 19 427
Gregory R. Kardos United States 7 217 0.8× 134 1.0× 41 0.4× 57 0.7× 21 0.3× 9 353
Laurie MacKenzie United States 9 266 1.0× 53 0.4× 50 0.5× 87 1.1× 61 1.0× 9 375
Sudhakar Manda India 10 260 1.0× 72 0.5× 217 2.0× 48 0.6× 17 0.3× 12 496

Countries citing papers authored by Alain Pierré

Since Specialization
Citations

This map shows the geographic impact of Alain Pierré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Pierré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Pierré more than expected).

Fields of papers citing papers by Alain Pierré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Pierré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Pierré. The network helps show where Alain Pierré may publish in the future.

Co-authorship network of co-authors of Alain Pierré

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Pierré. A scholar is included among the top collaborators of Alain Pierré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Pierré. Alain Pierré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Loriot, Yohann, Pierre Mordant, Olivier Geneste, et al.. (2014). Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer. Cell Death and Disease. 5(9). e1423–e1423. 36 indexed citations
2.
Maire, Virginie, Céline Baldeyron, Marion Richardson, et al.. (2013). TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer. PLoS ONE. 8(5). e63712–e63712. 119 indexed citations
3.
Loriot, Yohann, Pierre Mordant, Andrea Gombos, et al.. (2012). Abstract 4891: Radiation enhances the efficacy of Bcl-2 and Bcl-XL inhibition in small cell lung cancer: A new concept of using radiation for targeted therapy through contextual oncogene addiction. Cancer Research. 72(8_Supplement). 4891–4891. 1 indexed citations
4.
Geneste, Olivier, Thierry Le Diguarher, Patrick Casara, et al.. (2012). Abstract 2782: Bcl-2 selective antagonists show antitumor activity without dose limiting platelet toxicity. Cancer Research. 72(8_Supplement). 2782–2782.
5.
Hương, Đoàn Thị Mai, Thomas Gaslonde, Sylvie Michel, et al.. (2005). Design, Synthesis, and Cytotoxic Activity of Michael Acceptors and Enol Esters in the Benzo[b]acronycine Series. Chemical and Pharmaceutical Bulletin. 53(8). 919–922. 6 indexed citations
6.
Aligiannis, Nektarios, Nicole Pouli, Panagiotis Marakos, et al.. (2000). Design, Synthesis and Biological Activity of 7-O-(4-O-Acetyl-3-iodo-2,3,6-trideoxy-.ALPHA.-L-arabino-hexopyranosyl)daunomycinone and 7-O-(3-Chloro-2,3,6-trideoxy-4-O-propanoyl-.ALPHA.-L-lyxo-hexopyranosyl)daunomycinone.. Chemical and Pharmaceutical Bulletin. 48(1). 150–153. 1 indexed citations
7.
Michel, Sylvie, François Tillequin, Michel Koch, et al.. (2000). Synthesis and Cytotoxic and Antitumor Activity of Benzo[b]pyrano[3,2-h]acridin-7-one Analogues of Acronycine. Journal of Medicinal Chemistry. 43(12). 2395–2402. 69 indexed citations
8.
9.
Poncet, Joël, et al.. (1998). Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10. Bioorganic & Medicinal Chemistry Letters. 8(20). 2855–2858. 4 indexed citations
10.
Magiatis, Prokopios, Sofia Mitaku, Alexios‐Léandros Skaltsounis, et al.. (1998). Synthesis and Biological Activity of Esters in the trans-1,2-Dihydroxy-1,2-dihydroacronycine Series. Journal of Natural Products. 61(2). 198–201. 20 indexed citations
11.
Kraus‐Berthier, Laurence, et al.. (1997). Experimental Antitumour Activity of S 16020-2 in a Panel of Human Tumours. European Journal of Cancer. 33(11). 1881–1887. 14 indexed citations
12.
Perez, Valérie, et al.. (1993). Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.. PubMed. 13(4). 985–90. 7 indexed citations
13.
Pierré, Alain, et al.. (1993). [In vitro characterization of S9788, a new modulator of multidrug resistance].. PubMed. 80(4). 310–25. 4 indexed citations
14.
15.
Pierré, Alain, Theresa Dunn, Laurence Kraus‐Berthier, et al.. (1992). In vitro andin vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative. Investigational New Drugs. 10(3). 137–148. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by An‐Chi Tsai Breakdown of academic impact, for papers by Gabriela Kořínková Breakdown of academic impact, for papers by Nagashayana Natesh Breakdown of academic impact, for papers by Ram Kumar Singh Breakdown of academic impact, for papers by Christine Basmadjian Breakdown of academic impact, for papers by J Duraj Breakdown of academic impact, for papers by James D. Liddil Breakdown of academic impact, for papers by Gregory R. Kardos Breakdown of academic impact, for papers by Laurie MacKenzie Breakdown of academic impact, for papers by Sudhakar Manda
Rankless by CCL
2026